Suppression of matrix metalloproteinase production from nasal fibroblasts by fluticasone propionate in vitro

Acta Otolaryngol. 2004 Oct;124(8):964-9. doi: 10.1080/00016480310016947.

Abstract

Objective: To examine the influence of fluticasone propionate (FP) on matrix metalloproteinase (MMP) production from nasal polyp fibroblasts in vitro.

Material and methods: Fibroblasts derived from five nasal polyps were stimulated with tumor necrosis factor (TNF)-alpha in the presence of various concentrations of FP. The influence of FP on MMP production was assessed by examining the levels of MMP-2 and -9 in culture supernatants using ELISA. We also examined the influence of FP on MMP mRNA expression using reverse transcriptase polymerase chain reaction.

Results: The addition of FP caused significant suppression of MMP-2 and -9 production from nasal polyp fibroblasts in response to TNF-alpha stimulation. MMP mRNA expression was also suppressed by the addition of FP to cell cultures. The minimum concentration of the agent required to cause suppression was 10(-5) M.

Conclusion: These results suggest that the inhibitory action of FP on tissue remodeling may underlie the clinical efficacy of corticosteroids in nasal polyposis.

MeSH terms

  • Adult
  • Androstadienes / pharmacology*
  • Androstadienes / therapeutic use
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use
  • Cells, Cultured
  • Female
  • Fibroblasts / drug effects*
  • Fibroblasts / enzymology
  • Fluticasone
  • Gene Expression Regulation, Enzymologic / drug effects
  • Humans
  • Male
  • Matrix Metalloproteinase Inhibitors
  • Matrix Metalloproteinases / genetics
  • Matrix Metalloproteinases / metabolism*
  • Middle Aged
  • Nasal Polyps / drug therapy
  • Nasal Polyps / enzymology
  • Nasal Polyps / pathology*
  • RNA, Messenger / metabolism
  • Tissue Inhibitor of Metalloproteinases / antagonists & inhibitors
  • Tissue Inhibitor of Metalloproteinases / genetics
  • Tissue Inhibitor of Metalloproteinases / metabolism

Substances

  • Androstadienes
  • Anti-Inflammatory Agents
  • Matrix Metalloproteinase Inhibitors
  • RNA, Messenger
  • Tissue Inhibitor of Metalloproteinases
  • Fluticasone
  • Matrix Metalloproteinases